Sight Sciences, Inc. SGHT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 88.39M | 83.38M | 79.55M | 77.36M | 76.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.39M | 83.38M | 79.55M | 77.36M | 76.05M |
| Cost of Revenue | 10.83M | 10.04M | 11.00M | 10.70M | 10.61M |
| Gross Profit | 77.56M | 73.34M | 68.55M | 66.67M | 65.44M |
| SG&A Expenses | 88.06M | 84.97M | 86.08M | 89.16M | 94.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 109.09M | 105.85M | 109.81M | 114.46M | 121.41M |
| Operating Income | -20.70M | -22.48M | -30.25M | -37.10M | -45.36M |
| Income Before Tax | -28.34M | -29.79M | -37.27M | -38.42M | -46.07M |
| Income Tax Expenses | 58.00K | -32.00K | -20.00K | 10.00K | 40.00K |
| Earnings from Continuing Operations | -28.40 | -29.76 | -37.25 | -38.43 | -46.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.40M | -29.76M | -37.25M | -38.43M | -46.11M |
| EBIT | -20.70M | -22.48M | -30.25M | -37.10M | -45.36M |
| EBITDA | -20.28M | -22.07M | -29.81M | -36.61M | -44.81M |
| EPS Basic | -0.52 | -0.56 | -0.71 | -0.74 | -0.90 |
| Normalized Basic EPS | -0.26 | -0.29 | -0.38 | -0.46 | -0.56 |
| EPS Diluted | -0.52 | -0.56 | -0.71 | -0.74 | -0.90 |
| Normalized Diluted EPS | -0.26 | -0.29 | -0.38 | -0.46 | -0.56 |
| Average Basic Shares Outstanding | 216.66M | 213.91M | 211.22M | 208.57M | 206.29M |
| Average Diluted Shares Outstanding | 216.66M | 213.91M | 211.22M | 208.57M | 206.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |